Immunonutrition in Operated-on Gastric Cancer Patients: An Update
Author Information
Author(s): Triantafillidis John K., Malgarinos Konstantinos
Primary Institution: Metropolitan General Hospital, Athens, Greece
Hypothesis
The study aims to evaluate the effects of enteral immune nutrition (EIN) on immune responses and clinical outcomes in gastric cancer patients undergoing surgery.
Conclusion
Perioperative administration of enteral immune nutrition reduces postoperative complications and length of hospital stay but does not improve patient survival.
Supporting Evidence
- Enteral immune nutrition enhances immune responses in gastric cancer patients.
- Patients receiving EIN had shorter hospital stays and fewer postoperative complications.
- Meta-analyses support the efficacy of EIN in reducing infectious complications.
Takeaway
Giving special nutrition to patients with stomach cancer before and after surgery helps them heal better and stay in the hospital for less time.
Methodology
The study conducted a systematic review and meta-analysis of clinical trials and studies on the effects of EIN in gastric cancer patients.
Potential Biases
Some studies had small sample sizes and heterogeneity in patient conditions, which could introduce bias.
Limitations
The studies included varied in patient nutritional status, product types, and administration periods, which may affect the results.
Participant Demographics
The study included gastric cancer patients, with some studies focusing on those with cachexia.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website